NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 103 filers reported holding NURIX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,298 | -29.7% | 52,328 | -10.7% | 0.00% | -100.0% |
| Q2 2023 | $585,185 | +140.5% | 58,577 | +113.8% | 0.00% | – |
| Q1 2023 | $243,312 | -19.1% | 27,400 | +0.0% | 0.00% | – |
| Q4 2022 | $300,753 | -20.0% | 27,391 | -5.1% | 0.00% | – |
| Q3 2022 | $376,000 | +90.9% | 28,850 | +84.7% | 0.00% | – |
| Q2 2022 | $197,000 | -3.0% | 15,619 | +7.9% | 0.00% | – |
| Q1 2022 | $203,000 | -48.7% | 14,474 | +5.7% | 0.00% | – |
| Q4 2021 | $396,000 | -3.6% | 13,695 | -0.0% | 0.00% | – |
| Q3 2021 | $411,000 | +50.5% | 13,698 | +32.8% | 0.00% | – |
| Q2 2021 | $273,000 | -10.8% | 10,313 | +5.0% | 0.00% | – |
| Q1 2021 | $306,000 | -47.6% | 9,826 | -44.7% | 0.00% | – |
| Q4 2020 | $584,000 | – | 17,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |